We will Cover!
The device is the interface between the drug and the patient. Implementing a medical device for self-administration of injectable drugs is complex and requires a series of aspects to be considered. This webinar provides key insights along the entire process starting from the liquid-stable to a successful pen/autoinjector therapy, from a medical device perspective So, some of the capabilities that we would cover are: .
The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 35 years’ experience. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. The company is headquartered in Burgdorf, Switzerland, and has a global network of production facilities, subsidiaries and distribution partners employing a staff of around 1,900 employees worldwide. Our name reflects our expertise: “ipso” means “self” and “med” stands for medication. Hence our company name perfectly illustrates our core business: to market our innovative, high-quality and reliable products and services which allow patients to administer their own medication in a safe and simple way. With our injection and infusion systems and related services, we help millions of people, most of them diabetics, to enjoy the best possible quality of life. We strive for long-term and trusting relationships with our business partners that are characterized by openness and reliability. .
Reg Link Registration (gotowebinar.com)